Academic Journal
View in EDS
PDF Full Text

Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.

Bibliographic Details
Title: Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.
Authors: Ada Ao, Brian J Morrison, Heiman Wang, J Alejandro López, Brent A Reynolds, Jianrong Lu
Source: PLoS ONE, Vol 6, Iss 4, p e18810 (2011)
Publisher Information: Public Library of Science (PLoS), 2011.
Publication Year: 2011
Collection: LCC:Medicine
LCC:Science
Subject Terms: Medicine, Science
More Details: Estrogen signaling plays a critical role in the pathogenesis of breast cancer. Because the majority of breast carcinomas express the estrogen receptor ERα, endocrine therapy that impedes estrogen-ER signaling reduces breast cancer mortality and has become a mainstay of breast cancer treatment. However, patients remain at continued risk of relapse for many years after endocrine treatment. It has been proposed that cancer recurrence may be attributed to cancer stem cells (CSCs)/tumor-initiating cells (TICs). Previous studies in breast cancer have shown that such cells can be enriched and propagated in vitro by culturing the cells in suspension as mammospheres/tumorspheres. Here we established tumorspheres from ERα-positive human breast cancer cell line MCF7 and investigated their response to antiestrogens Tamoxifen and Fulvestrant. The tumorsphere cells express lower levels of ERα and are more tumorigenic in xenograft assays than the parental cells. Both 4-hydroxytamoxifen (4-OHT) and Fulvestrant attenuate tumorsphere cell proliferation, but only 4-OHT at high concentrations interferes with sphere formation. However, treated tumorsphere cells retain the self-renewal capacity. Upon withdrawal of antiestrogens, the treated cells resume tumorsphere formation and their tumorigenic potential remains undamaged. Depletion of ERα shows that ERα is dispensable for tumorsphere formation and xenograft tumor growth in mice. Surprisingly, ERα-depleted tumorspheres display heightened sensitivity to 4-OHT and their sphere-forming capacity is diminished after the drug is removed. These results imply that 4-OHT may inhibit cellular targets besides ERα that are essential for tumorsphere growth, and provide a potential strategy to sensitize tumorspheres to endocrine treatment.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1932-6203
Relation: http://europepmc.org/articles/PMC3077404?pdf=render; https://doaj.org/toc/1932-6203
DOI: 10.1371/journal.pone.0018810
Access URL: https://doaj.org/article/acac73dc665c40f8b44a3b1c09552647
Accession Number: edsdoj.73dc665c40f8b44a3b1c09552647
Database: Directory of Open Access Journals
FullText Links:
  – Type: pdflink
    Url: https://content.ebscohost.com/cds/retrieve?content=AQICAHjPtM4BHU3ZchRwgzYmadcigk49r9CVlbU7V5F6lgH7WwHbWWEiO-iPtvyfkMDNcq_aAAAA4TCB3gYJKoZIhvcNAQcGoIHQMIHNAgEAMIHHBgkqhkiG9w0BBwEwHgYJYIZIAWUDBAEuMBEEDD-Ch9qBal13y6AE8wIBEICBmfa6GG3dfaurWmSTPmXb3J8gjh5x-nTXZX3C32zaBL3QZ5HNChvoQAxtVj8rYkonLPDLByaCfnBj0d673UmYEAfL-fDY53aDpwCnyiS1q_WS5Tt3G59iOy0XD1EkILjeGzhtpQI1NRTNTliJdfpsJBZAqnAmRX8EhHD6AsNgl3ecQvA0sFfSI8DGbBHHqZ_O8EySRvY-9aVmLA==
Text:
  Availability: 0
CustomLinks:
  – Url: https://doaj.org/article/acac73dc665c40f8b44a3b1c09552647
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from Directory of Open Access Journals
    MouseOverText: View record from Directory of Open Access Journals
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=19326203&ISBN=&volume=6&issue=4&date=20110401&spage=e18810&pages=&title=PLoS ONE&atitle=Response%20of%20estrogen%20receptor-positive%20breast%20cancer%20tumorspheres%20to%20antiestrogen%20treatments.&aulast=Ada%20Ao&id=DOI:10.1371/journal.pone.0018810
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.73dc665c40f8b44a3b1c09552647
RelevancyScore: 843
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 842.694152832031
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ada+Ao%22">Ada Ao</searchLink><br /><searchLink fieldCode="AR" term="%22Brian+J+Morrison%22">Brian J Morrison</searchLink><br /><searchLink fieldCode="AR" term="%22Heiman+Wang%22">Heiman Wang</searchLink><br /><searchLink fieldCode="AR" term="%22J+Alejandro+López%22">J Alejandro López</searchLink><br /><searchLink fieldCode="AR" term="%22Brent+A+Reynolds%22">Brent A Reynolds</searchLink><br /><searchLink fieldCode="AR" term="%22Jianrong+Lu%22">Jianrong Lu</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: PLoS ONE, Vol 6, Iss 4, p e18810 (2011)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Public Library of Science (PLoS), 2011.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2011
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Medicine<br />LCC:Science
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Science%22">Science</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Estrogen signaling plays a critical role in the pathogenesis of breast cancer. Because the majority of breast carcinomas express the estrogen receptor ERα, endocrine therapy that impedes estrogen-ER signaling reduces breast cancer mortality and has become a mainstay of breast cancer treatment. However, patients remain at continued risk of relapse for many years after endocrine treatment. It has been proposed that cancer recurrence may be attributed to cancer stem cells (CSCs)/tumor-initiating cells (TICs). Previous studies in breast cancer have shown that such cells can be enriched and propagated in vitro by culturing the cells in suspension as mammospheres/tumorspheres. Here we established tumorspheres from ERα-positive human breast cancer cell line MCF7 and investigated their response to antiestrogens Tamoxifen and Fulvestrant. The tumorsphere cells express lower levels of ERα and are more tumorigenic in xenograft assays than the parental cells. Both 4-hydroxytamoxifen (4-OHT) and Fulvestrant attenuate tumorsphere cell proliferation, but only 4-OHT at high concentrations interferes with sphere formation. However, treated tumorsphere cells retain the self-renewal capacity. Upon withdrawal of antiestrogens, the treated cells resume tumorsphere formation and their tumorigenic potential remains undamaged. Depletion of ERα shows that ERα is dispensable for tumorsphere formation and xenograft tumor growth in mice. Surprisingly, ERα-depleted tumorspheres display heightened sensitivity to 4-OHT and their sphere-forming capacity is diminished after the drug is removed. These results imply that 4-OHT may inhibit cellular targets besides ERα that are essential for tumorsphere growth, and provide a potential strategy to sensitize tumorspheres to endocrine treatment.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1932-6203
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: http://europepmc.org/articles/PMC3077404?pdf=render; https://doaj.org/toc/1932-6203
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1371/journal.pone.0018810
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/acac73dc665c40f8b44a3b1c09552647" linkWindow="_blank">https://doaj.org/article/acac73dc665c40f8b44a3b1c09552647</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.73dc665c40f8b44a3b1c09552647
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.73dc665c40f8b44a3b1c09552647
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0018810
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e18810
    Subjects:
      – SubjectFull: Medicine
        Type: general
      – SubjectFull: Science
        Type: general
    Titles:
      – TitleFull: Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ada Ao
      – PersonEntity:
          Name:
            NameFull: Brian J Morrison
      – PersonEntity:
          Name:
            NameFull: Heiman Wang
      – PersonEntity:
          Name:
            NameFull: J Alejandro López
      – PersonEntity:
          Name:
            NameFull: Brent A Reynolds
      – PersonEntity:
          Name:
            NameFull: Jianrong Lu
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1